NO178260C - Indolderivater, mellomproduktforbindelser for deres fremstilling, anvendelse derav samt farmasöytisk preparat - Google Patents

Indolderivater, mellomproduktforbindelser for deres fremstilling, anvendelse derav samt farmasöytisk preparat

Info

Publication number: NO178260C
Authority: NO; Norway
Prior art keywords: alkyl; alkylamino; phenyl; benzyl; optionally substituted
Prior art date: 1991-03-26

Application number

NO921141A

Other languages

English (en)

Norwegian (no)

Other versions

NO921141L (no

NO178260B (no

NO921141D0 (no

Inventor

Didier Festal

Denis Descours

Robert Bellemin

Jacques Decerprit

Original Assignee

Lipha

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-26

Filing date

1992-03-24

Publication date

1996-02-21

1992-03-24 Application filed by Lipha filed Critical Lipha

1992-03-24 Publication of NO921141D0 publication Critical patent/NO921141D0/no

1992-09-28 Publication of NO921141L publication Critical patent/NO921141L/no

1995-11-13 Publication of NO178260B publication Critical patent/NO178260B/no

1996-02-21 Publication of NO178260C publication Critical patent/NO178260C/no

Links

229940054051 antipsychotic indole derivative Drugs 0.000 title abstract 2
150000002475 indoles Chemical class 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 5
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 4
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
125000000753 cycloalkyl group Chemical group 0.000 abstract 3
125000003342 alkenyl group Chemical group 0.000 abstract 2
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000004414 alkyl thio group Chemical group 0.000 abstract 1
230000000879 anti-atherosclerotic effect Effects 0.000 abstract 1
230000003178 anti-diabetic effect Effects 0.000 abstract 1
239000003472 antidiabetic agent Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
230000000055 hyoplipidemic effect Effects 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1
-1 polymethylene Polymers 0.000 abstract 1
125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Communicable Diseases (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Indole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO921141A 1991-03-26 1992-03-24 Indolderivater, mellomproduktforbindelser for deres fremstilling, anvendelse derav samt farmasöytisk preparat NO178260C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9103618A FR2674522B1 (fr)	1991-03-26	1991-03-26	Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.

Publications (4)

Publication Number	Publication Date
NO921141D0 NO921141D0 (no)	1992-03-24
NO921141L NO921141L (no)	1992-09-28
NO178260B NO178260B (no)	1995-11-13
NO178260C true NO178260C (no)	1996-02-21

Family

ID=9411107

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO921141A NO178260C (no)	1991-03-26	1992-03-24	Indolderivater, mellomproduktforbindelser for deres fremstilling, anvendelse derav samt farmasöytisk preparat

Country Status (25)

Country	Link
US (1)	US5219859A (de)
EP (1)	EP0506532B1 (de)
JP (1)	JPH0597802A (de)
KR (1)	KR950007753B1 (de)
AT (1)	ATE111078T1 (de)
AU (1)	AU658609B2 (de)
CA (1)	CA2063170A1 (de)
CS (1)	CS89592A3 (de)
DE (1)	DE69200378T2 (de)
DK (1)	DK0506532T3 (de)
ES (1)	ES2064149T3 (de)
FR (1)	FR2674522B1 (de)
HU (1)	HUT65489A (de)
IE (1)	IE65366B1 (de)
IL (1)	IL101248A (de)
MA (1)	MA22474A1 (de)
MX (1)	MX9201365A (de)
NO (1)	NO178260C (de)
NZ (1)	NZ242078A (de)
OA (1)	OA09573A (de)
RU (1)	RU2074179C1 (de)
SI (1)	SI9210305A (de)
TN (1)	TNSN92022A1 (de)
YU (1)	YU30592A (de)
ZA (1)	ZA922163B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2687402B1 (fr) *	1992-02-14	1995-06-30	Lipha	Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
RU94046149A (ru) *	1992-05-28	1996-11-27	Пфайзер Инк. (US)	Новые n-арил и n-гетероарил производные мочевины как ингибиторы ацил кофермента а:холестерин ацил трансферазы (асат) фармацевтическая композиция, способ ингибирования (асат)
NZ250916A (en) *	1993-02-27	1995-08-28	Nihon Nohyaku Co Ltd	N-heteroaryl-n'-phenylureas, their use as acat inhibitors
IL109568A0 (en) *	1993-05-19	1994-08-26	Fujisawa Pharmaceutical Co	Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
US5952354A (en) *	1993-07-21	1999-09-14	American Home Products Corporation	Tris carbamic acid esters: inhibitors of cholesterol absorption
DE4401893A1 (de) *	1994-01-24	1995-07-27	Bayer Ag	Substituierte Arylharnstoffe
JP3720395B2 (ja)	1994-09-20	2005-11-24	京都薬品工業株式会社	新規ヘテロ環誘導体、その製造方法およびその医薬用途
KR100241643B1 (ko) *	1995-06-06	2000-03-02	디. 제이. 우드	당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체
MX9709875A (es) *	1995-06-06	1998-03-31	Pfizer	N-(indol-2-carbonil)-glicinamidas substituidas y derivados como inhibidores de glicogeno fosforilasa, composiciones que las contienen y uso de las mismas.
US6297269B1 (en)	1995-06-06	2001-10-02	Pfizer Inc.	Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
NZ299242A (en) *	1995-09-11	1997-12-19	Nihon Nohyaku Co Ltd	N-phenyl-n'-(phenyl substituted imidazol-5-yl, -oxazol-4-yl, and -thiazol-4-yl)urea derivatives
KR100388345B1 (ko) *	1995-10-05	2004-03-30	교토 야쿠힝 고교 가부시키가이샤	신규헤테로시클릭유도체및이것의의약용도
EP0773218A1 (de) *	1995-11-13	1997-05-14	Mitsubishi Chemical Corporation	N-(Piperazinylalkoxyphenyl)-N'-phenylalkylharnstoffderivate als ACAT-Hemmer zur Atherosklerosebehandlung
DE122010000020I1 (de) *	1996-04-25	2010-07-08	Prosidion Ltd	Verfahren zur Senkung des Blutglukosespiegels in Säugern
FR2763334A1 (fr) *	1997-05-13	1998-11-20	Lipha	Derives anthraniliques
NZ503963A (en) *	1997-12-16	2002-09-27	Warner Lambert Co	1-substituted-1-aminomethyl-cycloalkane derivatives, or gabapentin analogues, preparation and use in the treatment of neurological disorders
CN1279667A (zh) *	1997-12-16	2001-01-10	沃尼尔·朗伯公司	4(3)取代－4(3)－氨基甲基－(硫代)吡喃(噻喃)或－哌啶衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途
WO1999031074A2 (en) *	1997-12-16	1999-06-24	Warner-Lambert Company	((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
SK282727B6 (sk)	1997-12-19	2002-11-06	Slovakofarma, A. S.	1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
US6277877B1 (en)	2000-08-15	2001-08-21	Pfizer, Inc.	Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
WO2002048150A2 (en)	2000-11-02	2002-06-20	The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
EP1501800A1 (de) *	2002-05-03	2005-02-02	Warner-Lambert Company LLC	Bombesin antagonisten
AU2003252638B8 (en) *	2002-07-17	2009-03-05	Kyoto Pharmaceutical Industries, Ltd.	Novel indoline compound and medicinal use thereof
EP1615900A1 (de)	2003-04-01	2006-01-18	Eli Lilly And Company	Benzisothiazol-3-on-carbonsäureamide als phospholipase inhibitoren
KR20060111898A (ko) *	2003-08-29	2006-10-30	교와 가부시키가이샤	지질-풍부-플라크의 안정화 방법 및 파열 예방방법
BRPI0619263A2 (pt)	2005-11-30	2011-09-27	Hoffmann La Roche	indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis
EP1957488B1 (de)	2005-11-30	2009-09-09	F.Hoffmann-La Roche Ag	3-amino-2-arylpropylazaindole und anwendungen davon
RU2361581C2 (ru) *	2007-09-14	2009-07-20	Закрытое Акционерное Общество "Мастерклон"	Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
SK287385B6 (sk)	2007-11-27	2010-08-09	Hameln-Rds, A. S.	1,3-Disubstituované močoviny, spôsob ich prípravy a použitia
CN104628621A (zh) *	2015-01-22	2015-05-20	湖南华腾制药有限公司	一种氟取代吲哚衍生物的制备方法
EP3519816A4 (de)	2016-09-29	2020-05-06	The Regents of the University of California	Verbindungen zur erhöhung der neuronalen plastizität
CU20190106A7 (es)	2017-06-26	2020-11-30	Lunella Biotech Inc	Mitocetoscinas: agentes terapéuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en células cancerosas
KR102946120B1 (ko)	2019-02-27	2026-03-30	더 리젠츠 오브 더 유니버시티 오브 캘리포니아	뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클
WO2022221415A2 (en)	2021-04-13	2022-10-20	The Regents Of The University Of California	Tetracyclic compounds for treating brain disorders
JP2025502615A (ja)	2021-12-15	2025-01-28	デリックスセラピューティクス，インク．	フェノキシおよびベンジルオキシ置換サイコプラストゲンならびにその使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS55151505A (en) *	1979-05-14	1980-11-26	Kuraray Co Ltd	Indole agricultural and horticultural fungicide
CA1299174C (en) *	1987-02-02	1992-04-21	Michael Edward Flaugh	Alkylmelatonins
EP0375133A1 (de) *	1988-11-14	1990-06-27	The Upjohn Company	Alpha-amino-indol-3-essigsäure, verwendbar als antidiabetische, antifettleibige und antiarteriosklerotische Agenten
IL95584A (en) *	1989-09-07	1995-03-15	Abbott Lab	Indole-, benzoporene- and benzothiophene compounds including lipoxygenase-inhibiting compounds and pharmaceutical compounds containing them
WO1991004027A1 (en) *	1989-09-15	1991-04-04	Pfizer Inc.	New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
ATE130002T1 (de) *	1990-08-13	1995-11-15	Hoechst Roussel Pharma	1-(pyridinylalkyl)-1h-indole, -indoline und analoge.
FR2680366B1 (fr) *	1991-08-13	1995-01-20	Adir	Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
WO1993005020A1 (en) *	1991-09-06	1993-03-18	Merck & Co., Inc.	Indoles as inhibitors of hiv reverse transcriptase

1991
- 1991-03-26 FR FR9103618A patent/FR2674522B1/fr not_active Expired - Fee Related
1992
- 1992-03-16 IL IL10124892A patent/IL101248A/en not_active IP Right Cessation
- 1992-03-17 CA CA002063170A patent/CA2063170A1/en not_active Abandoned
- 1992-03-20 EP EP92400764A patent/EP0506532B1/de not_active Expired - Lifetime
- 1992-03-20 DK DK92400764.4T patent/DK0506532T3/da active
- 1992-03-20 AT AT92400764T patent/ATE111078T1/de active
- 1992-03-20 US US07/855,544 patent/US5219859A/en not_active Expired - Fee Related
- 1992-03-20 DE DE69200378T patent/DE69200378T2/de not_active Expired - Fee Related
- 1992-03-20 ES ES92400764T patent/ES2064149T3/es not_active Expired - Lifetime
- 1992-03-20 AU AU13094/92A patent/AU658609B2/en not_active Ceased
- 1992-03-20 NZ NZ242078A patent/NZ242078A/en unknown
- 1992-03-23 MA MA22763A patent/MA22474A1/fr unknown
- 1992-03-24 NO NO921141A patent/NO178260C/no unknown
- 1992-03-24 IE IE920937A patent/IE65366B1/en not_active IP Right Cessation
- 1992-03-25 JP JP4067252A patent/JPH0597802A/ja active Pending
- 1992-03-25 RU SU925011235A patent/RU2074179C1/ru active
- 1992-03-25 CS CS92895A patent/CS89592A3/cs unknown
- 1992-03-25 HU HU9200997A patent/HUT65489A/hu unknown
- 1992-03-25 ZA ZA922163A patent/ZA922163B/xx unknown
- 1992-03-26 KR KR1019920005020A patent/KR950007753B1/ko not_active Expired - Fee Related
- 1992-03-26 YU YU30592A patent/YU30592A/sh unknown
- 1992-03-26 TN TNTNSN92022A patent/TNSN92022A1/fr unknown
- 1992-03-26 SI SI9210305A patent/SI9210305A/sl unknown
- 1992-03-26 OA OA60177A patent/OA09573A/fr unknown
- 1992-03-26 MX MX9201365A patent/MX9201365A/es not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0506532B1 (de)	1994-09-07
ATE111078T1 (de)	1994-09-15
KR920018022A (ko)	1992-10-21
HUT65489A (en)	1994-06-28
DE69200378D1 (de)	1994-10-13
MA22474A1 (fr)	1992-10-01
NO921141L (no)	1992-09-28
CS89592A3 (en)	1992-10-14
JPH0597802A (ja)	1993-04-20
EP0506532A1 (de)	1992-09-30
NO178260B (no)	1995-11-13
FR2674522B1 (fr)	1993-07-16
FR2674522A1 (fr)	1992-10-02
AU658609B2 (en)	1995-04-27
CA2063170A1 (en)	1992-09-27
AU1309492A (en)	1992-10-01
IE65366B1 (en)	1995-10-18
KR950007753B1 (ko)	1995-07-14
ES2064149T3 (es)	1995-01-16
DE69200378T2 (de)	1995-03-09
NZ242078A (en)	1994-10-26
HU9200997D0 (en)	1992-05-28
SI9210305A (en)	1996-02-29
NO921141D0 (no)	1992-03-24
YU30592A (sh)	1994-12-28
US5219859A (en)	1993-06-15
DK0506532T3 (da)	1995-02-20
IE920937A1 (en)	1992-10-07
TNSN92022A1 (fr)	1993-06-08
MX9201365A (es)	1992-10-01
OA09573A (fr)	1993-01-31
IL101248A (en)	1996-12-05
IL101248A0 (en)	1992-11-15
ZA922163B (en)	1993-09-27
RU2074179C1 (ru)	1997-02-27

Publication	Publication Date	Title
AU658609B2 (en)	1995-04-27	New indole derivatives, preparation processes and medicinal products containing them
PT96255A (pt)	1991-09-30	Processo para a preparacao de novos derivados da 1-naftil-piperazina
FI912142L (fi)	1991-11-05	Menetelmä uusien, terapeuttisesti käyttökelpoisten 5-(2-((2-aryyli-2-hydroksietyyli)amino)propyyli)-1,3-bentsodioksolijohdannaisten valmistamiseksi
NO308248B1 (no)	2000-08-21	Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat
ES2132284T3 (es)	1999-08-16	Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.
DK0662471T3 (da)	1998-12-21	Naphthalenderivater med affinitet over for melatonin-receptorer, fremgangsmåde til deres fremstilling og farmaceutiske samm
IT1250749B (it)	1995-04-21	Composti eterociclici ad attivita' a ii antagonista
NO20050664L (no)	2005-04-15	2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
ATE54149T1 (de)	1990-07-15	Neue silanderivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schaedlingsbekaempfungsmittel.
DK0450420T3 (da)	1995-02-20	Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
DK0916670T3 (da)	2003-09-15	Pyrrolo[3,2-b]pyridiner og deres anvendelse som 5-HT1f-agonister
NO982927L (no)	1998-06-23	Biologisk aktive benzotiazolon etanaminer
DK74185D0 (da)	1985-02-15	3-phenyl-2-propen-amin-derivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
DK406587D0 (da)	1987-08-04	1,4-dihydropyridinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
NO953913L (no)	1995-10-02	Perhydroisoindolderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene
HUT76480A (en)	1997-09-29	Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
DK414682A (da)	1983-03-18	N-sulfenylerede benzylsulfonamider, deres fremstilling og anvendelse som mikrobicider
DK115785A (da)	1985-09-15	Monosilylerede aiminophenylethylamin-derivater, fremgangsmaade til fremstilling deraf og deres anvendelse som vaekstfremmende midler
DK283189A (da)	1989-12-11	Phenothiazinderivater, deres fremstilling og farmaceutiske praeparater deraf
HUT42278A (en)	1987-07-28	Herbicidal compositions comprising 5-sulfamino-1-aryl-pyranol derivatives as active substance and process for preparing the active substances
ATE71367T1 (de)	1992-01-15	Verfahren zur herstellung von indolinen.
ES2194690T3 (es)	2003-12-01	Procedimiento de preparacion de oxazoles trisustituidos.